| # | Drug | Count |
|---|---|---|
| 0 | SECUKINUMAB | 8 |
| 1 | SOMATROPIN | 6 |
| 2 | GUSELKUMAB | 5 |
| 3 | USTEKINUMAB | 5 |
| 4 | ETANERCEPT | 4 |
| 5 | TUBERCULIN PURIFIED PROTEIN DERIVATIVE | 4 |
| 6 | GLATIRAMER ACETATE | 3 |
| 7 | IXEKIZUMAB | 3 |
| 8 | TERIPARATIDE | 3 |
| 9 | ADALIMUMAB | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | HUMAN ALBUMIN MICROSPHERES AND PERFLUTREN | 1 | 0.0071 |
| 1 | TUBERCULIN PURIFIED PROTEIN DERIVATIVE | 4 | 0.0021 |
| 2 | BRODALUMAB | 1 | 0.0005 |
| 3 | PRUCALOPRIDE | 1 | 0.0004 |
| 4 | LEVONORGESTREL AND ETHINYL ESTRADIOL | 1 | 0.0004 |
| 5 | FILGRASTIM-SNDZ | 1 | 0.0003 |
| 6 | AMIVANTAMAB-VMJW | 1 | 0.0003 |
| 7 | NABUMETONE | 1 | 0.0002 |
| 8 | CILTACABTAGENE AUTOLEUCEL | 1 | 0.0002 |
| 9 | GUSELKUMAB | 5 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Skin Test Antigen [EPC] | 4 | 0.0021 |
| 1 | Interleukin-17 Receptor A Antagonist [EPC] | 1 | 0.0005 |
| 2 | Interleukin-17A Antagonist [EPC] | 11 | 0.0003 |
| 3 | Recombinant Human Growth Hormone [EPC] | 4 | 0.0002 |
| 4 | Contrast Agent for Ultrasound Imaging [EPC] | 1 | 0.0002 |
| 5 | Interleukin-23 Antagonist [EPC] | 10 | 0.0001 |
| 6 | Antisense Oligonucleotide [EPC] | 1 | 0.0001 |
| 7 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 1 | 0.0001 |
| 8 | Recombinant Human Nerve Growth Factor [EPC] | 1 | 0.0001 |
| 9 | Hepatitis C Virus NS3/4A Protease Inhibitor [EPC] | 1 | 0.0001 |